About us
Who we are
who we are
NOWDiagnostics
(NOWDx)
Our Approach
NOWDiagnostics (NOWDx) develops and manufactures the First To Know® Syphilis Test as well as other diagnostic tests. Its patented approach enables virtually any immunological assay to be accurately performed in one step using a small amount of capillary blood, yielding results in minutes. With over 89 patents issued and pending, NOWDx’s First To Know and ADEXUSDx® product lines are available in markets worldwide.
Our History
Founded in 2013, with headquarters and manufacturing in Springdale, Arkansas, NOWDx envisions a world where people have greater access to in-home testing with results in minutes. NOWDx is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.
First to know
In the news
-
NOWDx to attend AMSUS 2025 Annual Meeting March 3-5
Read MoreNOWDiagnostics (NOWDx), the manufacturer of the First To Know® Syphilis Test, will be attending the AMSUS 2025 Annual Meeting in National Harbor, MD March 3-5, 2025 at Booth #117. Join us to see the First To Know® Syphilis Test firsthand – the over-the-counter in-home syphilis test that delivers an accurate result in just 15 minutes.…
-
First To Know – the only Over-the-Counter Home Test for Syphilis – Will Now Be Available Through the National Alliance of State and Territorial AIDS Directors, Building Healthy Online Communities and the TakeMeHome Initiative
Read More– Program Provides At-Risk Consumers Access to Free Tests Delivered At Home – SPRINGDALE, ARK. – January 22, 2025 – NOWDiagnostics, Inc. (NOWDx), a leader in developing over-the-counter (OTC) and point-of-care (POC) diagnostic tests, proudly announces that its First To Know® Syphilis Test has joined the innovative TakeMeHome initiative. In collaboration with NASTAD (National Alliance…
-
NOWDiagnostics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Read MoreCEO Robert Weigle to share NOWDx’s vision for transforming consumer healthcare through in-home testing with results in minutes, and highlight commitment to advancing OTC and POC diagnostic products, including novel FDA-authorized First To Know Syphilis Test.
Key Staff
